Tertiary Patents on Drugs Approved by the FDA

The findings of this cohort study suggest that policymakers and regulators should take steps to ensure that tertiary patents are not improperly listed in the Orange Book and that generic competition occurs in a timely fashion.

Authors

Institutions

Publication Details

Journal
JAMA Health Forum
Published
2026-01-02
DOI
https://doi.org/10.1001/jamahealthforum.2025.5909
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tertiary Patents on Drugs Approved by the FDA

Liam Bendicksen, Helen Mooney, Theodore W. Teng, Olivier J. Wouters et al.
JAMA Health Forum
Pharmaceutical Economics and Policy
article

Tertiary Patents on Drugs Approved by the FDA

Liam Bendicksen, Helen Mooney, Theodore W. Teng, Olivier J. Wouters, William B. Feldman, Sarah M. E. Gabriele, S. Sean Tu
article en

Abstract

The findings of this cohort study suggest that policymakers and regulators should take steps to ensure that tertiary patents are not improperly listed in the Orange Book and that generic competition occurs in a timely fashion.

JAMA Health ForumVol. 7(1)
Brigham and Women's Hospital (US), Harvard University (US), University of Alabama (US), Brown University (US), Yale University (US), Harvard College Observatory (US)
Openalex Percentile: Top 99%
Pharmaceutical Economics and Policy
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.